Zhonghua Li

Development of the triazole-fused pyrimidine derivatives as highly potent and reversible inhibitors of histone lysine specific demethylase 1 (LSD1/KDM1A)

Zhonghua Li, Lina Ding, Zhongrui Li et al. · Acta Pharmaceutica Sinica B · 2019 · 78 citations · Full text

An Isotope-Coded Photocleavable Probe for Quantitative Profiling of Protein <i>O</i>-GlcNAcylation

Jingchao Li, Zhonghua Li, Xiaotao Duan et al. · ACS Chemical Biology · 2019 · 74 citations

Discovery of [1,2,3]Triazolo[4,5-<i>d</i>]pyrimidine Derivatives as Novel LSD1 Inhibitors

Zhonghua Li, Xue‐qi Liu, Peng Geng et al. · ACS Medicinal Chemistry Letters · 2017 · 73 citations · Full text

Discovery of 5-Cyano-6-phenylpyrimidin Derivatives Containing an Acylurea Moiety as Orally Bioavailable Reversal Agents against P-Glycoprotein-Mediated Mutidrug Resistance

Bo Wang, Liying Ma, Jing‐Quan Wang et al. · Journal of Medicinal Chemistry · 2018 · 70 citations · Full text

Pharmaceutical Science, P-glycoprotein-mediated Mutidrug Resistance, Pharmacotherapy +16

Downregulation of KPNA2 in non-small-cell lung cancer is associated with Oct4 expression

Xiaolei Li, Lanling Jia, Mumu Shi et al. · Journal of Translational Medicine · 2013 · 59 citations · Full text